CD8A and neoplasm: From the proteomic analysis, scRNA‐seq and multiple immunofluorescence staining, we further verified that TECs inhibit CD8+ T cells by expressing PD‐L1, which induces T‐cell apoptosis, and helps cancer cells evade immune monitoring and killing, and promoting tumour progression from lepidic to acinar.52, 53